Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
Signaling involving chemokine receptor CXCR4 and its ligand SDF-1/CXL12 has been investigated for many years for its possible role in cancer progression and pathogenesis. Evidence emerging from clinical studies in recent years has further established diagnostic as well as prognostic importance of CX...
محفوظ في:
| المؤلف الرئيسي: | Reem Khaled M.E., Alsayed (author) |
|---|---|
| مؤلفون آخرون: | Khan, Abdul Q. (author), Ahmad, Fareed (author), Ansari, Abdul Wahid (author), Alam, Majid Ali (author), Buddenkotte, Jorg (author), Steinhoff, Martin (author), Uddin, Shahab (author), Ahmad, Aamir (author) |
| التنسيق: | article |
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1016/j.semcancer.2022.03.019 https://www.sciencedirect.com/science/article/pii/S1044579X2200075X http://hdl.handle.net/10576/48859 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
حسب: Reem Khaled M.E. Alsayed (17563251)
منشور في: (2022) -
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
حسب: Kirti S. Prabhu (4246144)
منشور في: (2024) -
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
حسب: Gulab Sher (12984698)
منشور في: (2022) -
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
حسب: Reem Saleh (3513056)
منشور في: (2020) -
Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes
حسب: Ammira-Sarah AL-Shabeeb Akil (18949477)
منشور في: (2020)